The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world clinical outcomes of locally advanced unresectable and de-novo metastatic pancreatic ductal adenocarcinoma: A multicenter retrospective study from Saudi Arabia.
 
Mohamed Aseafan
No Relationships to Disclose
 
Ali Alfakeeh
Research Funding - AstraZeneca (Inst)
 
Emad Tashkandi
No Relationships to Disclose
 
Mervat Mahrous
No Relationships to Disclose
 
Mohamed Alghamdi
No Relationships to Disclose
 
Bader Alshamsan
No Relationships to Disclose
 
Marwan Al-hajeili
No Relationships to Disclose
 
Safwan Bakhsh
No Relationships to Disclose
 
Kanan Alshammari
No Relationships to Disclose
 
Ali Alqahtani
No Relationships to Disclose
 
Shouki Bazarbashi
Honoraria - AstraZeneca; Bayer; BeiGene; Bristol-Myers Squibb; Hikma; Ipsen; Lilly; Merck Serono; Merck Sharp & Dohme; Newbridge Pharmaceuticals; Pfizer; Roche
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; HIKMA; Ipsen; Merck KGaA; Merck Sharp & Dohme; pfizer; Roche; Taiba
Research Funding - Astellas Pharma (Inst); Kite/Gilead (Inst); Lilly; Merck KGaA (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Hikma Pharmaceuticals; Ipsen; Janssen; Merck; SERVIER